Take a look at new work uncovering novel aspects of MHC degradation with exciting therapeutic implication to target tumor immune evasion – The Mark Foundation for Cancer Research

Take a look at new work uncovering novel aspects of MHC degradation with exciting therapeutic implication to target tumor immune evasion. We are proud to be a major sponsor of this work with a Mark Foundation ASPIRE award led by Jun Wang and Iannis Aifantis.

Out today Cell our latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. A great collaboration with Jun Wang and NYU Grossman School of Medicine.

Source: The Mark Foundation for Cancer Research / Twitter